Take Solutions

Which are the latest news on Take Solutions?

How big is Take Solutions?

As of 10th June, Take Solutions Ltd has a market capitalization of 448.00 Cr, with recent net sales of 54.19 Cr and net profit of 10.85 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Take Solutions Ltd has a market capitalization of 448.00 Cr, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 54.19 Cr, while the sum of Net Profit for the same period is 10.85 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2025. Shareholder's Funds are valued at 20.53 Cr, and Total Assets amount to 36.48 Cr.

Who are in the management team of Take Solutions?

The management team of Take Solutions includes H R Srinivasan (Non Executive Director), Shobana N S (Executive Director), P Srinivasan (Company Secretary & Compliance Officer), Chella Gowrishankar (Director), and four Independent Directors: Chandrasekaran Nagarajan, Rangasami Seshadri, Kiran Sharma, and Ramesh Gopal.

The management team of Take Solutions includes the following members:<BR><BR>1. H R Srinivasan - Non Executive Director<BR>2. Shobana N S - Executive Director<BR>3. P Srinivasan - Company Secretary & Compliance Officer<BR>4. Chella Gowrishankar - Director<BR>5. Chandrasekaran Nagarajan - Independent Director<BR>6. Rangasami Seshadri - Independent Director<BR>7. Kiran Sharma - Independent Director<BR>8. Ramesh Gopal - Independent Director<BR><BR>If you need more specific information about any of these individuals or their roles, feel free to ask!

Who are the peers of the Take Solutions?

Take Solutions' peers include Health X Platform, Hemant Surgical, Prevest Denpro, Nureca, Jeevan Scientific, Bilcare, and QMS Medical. Take Solutions has below-average management risk and growth, with a 1-year return of 239.04%, while Hemant Surgical leads with a return of 274.49%.

Peers: The peers of Take Solutions are Health X Platfor, Hemant Surgical, Prevest Denpro, Nureca, Jeevan Scienti., Bilcare, and QMS Medical.<BR><BR>Quality Snapshot: Excellent management risk is observed at Health X Platfor and Prevest Denpro, while Average management risk is found at Hemant Surgical and QMS Medical. Below Average management risk is noted for Take Solutions, Nureca, Jeevan Scienti., and Bilcare. Growth is rated as Good for Hemant Surgical, Average for Health X Platfor and QMS Medical, and Below Average for Take Solutions, Prevest Denpro, Nureca, Jeevan Scienti., and Bilcare. Capital Structure is rated as Excellent for Health X Platfor and Prevest Denpro, Good for Nureca, and Below Average for Take Solutions, Hemant Surgical, Jeevan Scienti., Bilcare, and QMS Medical.<BR><BR>Return Snapshot: Hemant Surgical has the highest 1-year return at 274.49%, while Prevest Denpro has the lowest at -22.52%. Take Solutions' 1-year return of 239.04% is significantly higher than that of Prevest Denpro. Additionally, Nureca, Bilcare, and QMS Medical have negative six-month returns.

Why is Take Solutions Ltd falling/rising?

As of 11-Jun, the stock price of Take Solutions Ltd is at 29.69, showing a slight decline but recent short-term gains. However, long-term performance is poor, with a year-to-date drop of 25.33% and a five-year decline of 57.49%, alongside decreasing investor participation.

As of 11-Jun, the stock price of Take Solutions Ltd is currently at 29.69, reflecting a slight decline of 0.04 or 0.13%. Despite this minor drop, the stock has shown some positive trends recently, having outperformed its sector by 2.41% today and experiencing gains for the last three consecutive days, with a total return of 1.59% during this period.<BR><BR>However, the overall performance over longer periods indicates significant challenges. Year-to-date, the stock has decreased by 25.33%, which is notably worse than the Sensex's decline of 13.36%. Additionally, the stock has seen a substantial drop of 57.49% over the past five years, contrasting sharply with the Sensex's gain of 40.70% in the same timeframe.<BR><BR>Investor participation appears to be declining, as evidenced by a 44.38% drop in delivery volume compared to the five-day average, which could indicate reduced interest or confidence among investors. While the stock is currently trading above its 5-day and 20-day moving averages, it remains below its longer-term moving averages (50-day, 100-day, and 200-day), suggesting that the stock may not be in a strong upward trend.<BR><BR>In summary, while there are short-term gains and a recent outperformance against the sector, the long-term performance and declining investor participation contribute to the stock's current price movement and overall outlook.

What does Take Solutions do?

Take Solutions Ltd is a micro-cap company in the Healthcare Services industry, providing services in Life Sciences, Software, and IT. As of March 2026, it reported net sales of 54 Cr and a net profit of 4 Cr, with a market cap of INR 448 Cr.

Overview:<BR>Take Solutions Ltd is a micro-cap company operating in the Healthcare Services industry, delivering domain-intensive services and solutions in Life Sciences, Software, and Information Technology.<BR><BR>History:<BR>Take Solutions Limited was incorporated on December 20, 2000. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 54 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: 4 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 448 Cr (Micro Cap) <BR><BR>Key Metrics:<BR>P/E: 104.00 <BR>Industry P/E: 20 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.01 <BR>Return on Equity: 13.74% <BR>Price to Book: 14.31 <BR><BR>Contact Details:<BR>Address: No 27 Tank Bund Road, Nungambakkam Chennai Tamil Nadu : 600034 <BR>Tel: 91-044-24617358/24617359 <BR>Email: secretarial@takesolutions.com <BR>Website: http://www.takesolutions.com

Should I buy, sell or hold Take Solutions Ltd?

Are Take Solutions Ltd latest results good or bad?

Take Solutions Ltd's latest results show a return to revenue with net sales of ₹54.19 crores and a net profit of ₹4.36 crores, but the company faces significant concerns due to negative operating margins, reliance on non-operating income, and the complete exit of promoters, indicating an unfavorable overall assessment.

Take Solutions Ltd's latest results for Q4 FY26 present a mixed picture that leans towards concern. On one hand, the company reported net sales of ₹54.19 crores, marking its first revenue after several quarters of zero sales, which is a positive sign of some operational activity resuming. Additionally, the consolidated net profit of ₹4.36 crores reflects a significant increase of 292.79% quarter-over-quarter, which might seem encouraging at first glance.<BR><BR>However, a deeper analysis reveals troubling underlying issues. The operating margin, excluding other income, was deeply negative at -1.51%, indicating that the core business remains unprofitable despite the revenue generation. The reported profit was heavily reliant on other income, which accounted for 118.81% of the profit before tax, raising serious questions about the sustainability and quality of the earnings.<BR><BR>Moreover, the complete exit of promoters from the company signals a lack of confidence in its recovery prospects. The company's financial health has deteriorated significantly over the years, with shareholder funds collapsing from ₹1,124.69 crores in March 2021 to just ₹20.53 crores in March 2025. <BR><BR>In summary, while the return to revenue generation is a positive development, the ongoing operational losses, reliance on non-operating income for profitability, and the complete promoter exit suggest that the results are more indicative of a speculative situation rather than a solid recovery. Therefore, the overall assessment of Take Solutions Ltd's latest results leans towards being unfavorable.

How has been the historical performance of Take Solutions?

Take Solutions has experienced a significant decline in financial performance, with net sales dropping from 2,212.90 crore in March 2020 to 0.00 crore in March 2025, although it reported a net profit of 37.47 crore in March 2025 after years of losses. Total assets also fell sharply from 2,464.45 crore to 36.48 crore during the same period.

Answer:<BR>The historical performance of Take Solutions shows a significant decline in net sales and profitability over the years, culminating in a net profit of 37.47 crore in March 2025 after several years of losses.<BR><BR>Breakdown:<BR>Take Solutions experienced a drastic drop in net sales from 2,212.90 crore in March 2020 to 0.00 crore in March 2025. The total operating income followed a similar trend, decreasing from 2,212.90 crore in March 2020 to 0.00 crore in March 2025. Operating profit (PBDIT) also fell sharply, moving from a profit of 195.29 crore in March 2020 to a loss of 7.47 crore in March 2025. The company reported a profit before tax of 0.74 crore in March 2025, a recovery from the previous years of losses, while profit after tax also showed a positive shift to 0.74 crore. The total assets decreased significantly from 2,464.45 crore in March 2020 to 36.48 crore in March 2025, reflecting a severe contraction in the company's financial position. Despite these challenges, the company managed to achieve a net cash inflow of 2.00 crore in March 2025, contrasting with the negative cash flows seen in prior years.

Who are the top shareholders of the Take Solutions?

The top shareholders of Take Solutions are Take Solutions Pte Limited, which holds 52.9% of the shares, and individual investors who collectively own 40.45%. There are no mutual funds or foreign institutional investors currently involved.

The top shareholders of Take Solutions include the promoters, with Take Solutions Pte Limited holding the largest share at 52.9%. Additionally, individual investors collectively hold 40.45% of the company's shares. There are no mutual funds or foreign institutional investors (FIIs) currently holding shares in the company.

When is the next results date for Take Solutions?

Take Solutions will announce its results on July 7, 2025.

Take Solutions will declare its results on 07 July 2025.

Is Take Solutions overvalued or undervalued?

As of May 31, 2024, Take Solutions is considered risky and overvalued due to a high PE ratio of 128.70, negative EV to EBIT of -16.66, and a troubling ROCE of -43.98%, especially when compared to peers like TCS and Infosys, while also underperforming the Sensex with a year-to-date return of -45.88%.

As of 31 May 2024, the valuation grade for Take Solutions has moved from attractive to risky, indicating a significant shift in its financial outlook. The company is currently deemed overvalued, particularly when considering its high PE ratio of 128.70 and a negative EV to EBIT of -16.66. Additionally, the return on capital employed (ROCE) stands at a concerning -43.98%, which further underscores the company's financial struggles.<BR><BR>When compared to peers, Take Solutions' valuation metrics are starkly unfavorable. For instance, TCS, which is rated attractive, has a PE ratio of 25.23, while Infosys, rated fair, has a PE of 24.32. The PEG ratio for Take Solutions is 1.26, which, while not excessively high, is still indicative of overvaluation relative to its peers. The company's recent stock performance has also lagged behind the Sensex, with a year-to-date return of -45.88% compared to the Sensex's 5.59%, reinforcing the perception of overvaluation in the current market context.

What is the technical trend for Take Solutions?

As of May 14, 2025, Take Solutions shows a mildly bearish trend overall, with mixed signals from MACD and bearish moving averages, despite a mildly bullish weekly MACD.

As of 14 May 2025, the technical trend for Take Solutions has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The moving averages on a daily basis are mildly bearish, and the Bollinger Bands show a bearish trend in both weekly and monthly time frames. The KST is mildly bullish weekly but bearish monthly, and Dow Theory reflects a mildly bearish position on the weekly chart with no trend on the monthly. Overall, the current technical stance is mildly bearish, driven primarily by the mixed signals from MACD and the bearish moving averages.

Has Take Solutions declared dividend?

Take Solutions Ltd has declared a 40% dividend, amounting to 0.4 per share, but the dividend yield is 0%. The company has experienced significant losses over various periods, with total returns ranging from -49.6% to -86.45%.

Take Solutions Ltd has declared a 40% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 40%<BR>- Amount per share: 0.4<BR>- Ex-date: 01 Aug 19<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -49.6%, the dividend return was 0%, resulting in a total return of -49.6%.<BR><BR>Over the past year, the price return was -55.81%, the dividend return was 0%, leading to a total return of -55.81%.<BR><BR>For the 2-year period, the price return was -50.72%, the dividend return was 0%, culminating in a total return of -50.72%.<BR><BR>In the 3-year span, the price return was -62.62%, the dividend return was 0%, which resulted in a total return of -62.62%.<BR><BR>Over the last 4 years, the price return was -86.45%, the dividend return was 0%, leading to a total return of -86.45%.<BR><BR>Finally, in the 5-year period, the price return was -85.18%, the dividend return was 0%, resulting in a total return of -85.18%.<BR><BR>Overall, while Take Solutions Ltd has declared a dividend, the company has not provided any dividend yield, and the total returns across all periods indicate significant losses, suggesting a challenging financial performance.